Article

galleonnews.com on 2022-07-20 07:58

2022 Global Respiratory Syncytial Virus (RSV) Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version

The global Respiratory Syncytial Virus (RSV) Therapeutics market was valued at 526.4 Million USD in 2021 and will grow with a CAGR of 5.51% from 2021

Related news